Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PTK2 contributors: shn/npt/pgu - updated : 07-05-2010
HGNC name PTK2 protein tyrosine kinase 2
HGNC id 9611
Location 8q24.3      Physical location : 141.668.501 - 142.011.332
Synonym name focal adhesion kinase 1
Synonym symbol(s) FAK1, FADK, pp125FAK, FAK
EC.number 2.7.10.1, 2.7.10.2
DNA
TYPE functioning gene
STRUCTURE 342.83 kb     32 Exon(s)
10 Kb 5' upstream gene genomic sequence study
regulatory sequence Promoter
cytosine-phosphate-guanine/HTF
Binding site   transcription factor
text structure 5'-flanking region is GC-rich and contains several potential transcription factor binding sites, including two NF-kappa B and p53 binding sites
MAPPING cloned Y linked N status confirmed
Map pter - D8S1743 - D8S1717 - PTK2 - D8S1727 - D8S1713 - cen
Physical map
COL22A1 8q24.3 collagen, type XXII, alpha 1 KCNK9 8q24.2 potassium channel, subfamily K, member 9 T1 8q24.3 Tularik gene 1 C8orf17 8q24.3 chromosome 8 open reading frame 17 CHRAC1 8q24.3 chromatin accessibility complex 1 EIF2C2 8q24 eukaryotic translation initiation factor 2C, 2 PTK2 8q24-qter PTK2 protein tyrosine kinase 2 KIAA0870 8q24.3 KIAA0870 protein KIAA1126 8q24.3 KIAA1126 protein LOC137485 8q24.3 hypothetical gene LOC137485 LOC389689 8 LOC389689 GPR20 8q24.2-q24.3 G protein-coupled receptor 20 PTP4A3 8q24.3 protein tyrosine phosphatase type IVA, member 3 LOC389690 8 similar to FLJ46354 protein LOC392273 8 similar to Dnajc8 protein FLJ31164 8q24.3 hypothetical protein FLJ31164 BAI1 8q24 brain-specific angiogenesis inhibitor 1 ARC 8q24.3 activity-regulated cytoskeleton-associated protein JRK 8q24.3 jerky homolog (mouse) PSCA 8q24.2 prostate stem cell antigen HSJ001348 8q24.3 cDNA for differentially expressed CO16 gene LOC51337 8q24.3 mesenchymal stem cell protein DSCD75 ARS LOC137797 8q24.3 similar to RGTR430 LYNX1 8q24.3 similar to RGTR430 E48 GML 8q24.3 GPI anchored molecule like protein CYP11B1 8q21 cytochrome P450, family 11, subfamily B, polypeptide 1
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
32 splicing 4442 - 1074 - 2004 15157737
32 splicing 4453 - 1052 - 2004 15157737
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestivemouth   highly
Endocrinethyroid   moderately
Nervousbrain   moderately
Reproductivemale systemtestis  moderately Homo sapiens
Respiratoryrespiratory tractlarynx  highly
 respiratory tracttrachea  highly
Urinarybladder   moderately
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Lymphoid    
cells
SystemCellPubmedSpeciesStageRna symbol
Lymphoid/Immunelymphocyte
ReproductiveSertoli cell Homo sapiens
cell lineage
cell lines lymphoid cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N-terminal FERM domain arranges into three lobes and regulates its kinase activity, and including a nuclear export signal NES1, and implicated in events at the cell cortex and in the nucleus that are crucial to cell behaviour and life-or-death decisions
  • a protein kinase domain including a nuclear export signal NES2
  • a NT2 domain, overexpressed and co-localized with IGF1R in pancreatic cells
  • focal adhesion targeting (FAT) domain binds specifically to the CD4 endocytosis motif
  • C-terminal domain can bind to a number of proteins, such as paxillin, talin, phosphoinositide 3-kinases (PI3 K) and the GTPase-activating protein ARHGAP26, leading to the localization of FAK to focal adhesions and reorganization of the actin cytoskeleton
  • conjugated Other
    HOMOLOGY
    interspecies ortholog to Ptk2, Rattus norvegicus
    ortholog to Ptk2, Mus musculus
    ortholog to PTK2, Pan troglodytes
    homolog to zgc:66114, Danio rerio
    Homologene
    FAMILY
  • FAK subfamily of protein tyrosine kinases
  • CATEGORY adhesion , enzyme , immunity/defense , regulatory
    SUBCELLULAR LOCALIZATION     plasma membrane,junction
        intracellular
    intracellular,cytoplasm,cytoskeleton
    intracellular,nucleus
    text
  • localized to focal adhesions
  • lamellipodium
  • apical plasma membrane
  • nuclear translocation of PTK2 reduces contact between PTK2 and SRC
  • basic FUNCTION
  • non receptor, protein tyrosine kinase, focal adhesion kinase, playing an important role in the response of migrating cells to mechanical input
  • mediating a direct interaction with the C terminal SH2 domain of phospholipase C (PCLG1)
  • primary mediator of integrin signaling after integrin mediated cell adhesion and PTK2 phosphorylation
  • involved in cell mobility
  • playing a potential role in oncogenic transformations resulting in increased kinase activity
  • plays crucial role in a variety of intracellular signaling, such as migration, proliferation, differentiation, and adhesion
  • promotes cell migration by regulating focal adhesion formation and turnover through multiple signaling connections
  • playing a necessary role for cell migration and tube formation
  • may be a critical signaling component involved in the regulation of angiogenesis
  • is functioning in cell migration, but fibril-forming collagen-induced PTK2 degradation is necessary for endothelial tube formation
  • plays a critical role in transformation and tumorigenesis and is aberrantly upregulated in many types of cancer
  • central component in integrin signalling, and in T lymphocytes, with CD4 localise to the same signalling complexes after stimulation by either the human immunodeficiency virus (HIV) gp120 glycoprotein or an antigen
  • mediates activation-loop independent phosphorylation, as well as Akt and ERK activation
  • playing a role in phosphorylation, signaling and stability of the IGF1R
  • critical tyrosine kinase that modulates cell adhesion, migration, proliferation and survival in response to extracellular signals
  • EMP2-FAK association is a significant functional cellular responses in the context of in vitro models of proliferative vitreoretinopathy
  • acts as a pivotal signal 'integrator', controlling and coordinating cellular responses that include cell migration, survival, proliferation and, epithelial tissue repair after DNA damage
  • PTK2 and IQGAP1 regulate melusin-dependent cardiomyocyte hypertrophy and survival through MAPK1/MAPK3 activation
  • CELLULAR PROCESS cell life, proliferation/growth
    cell life, cell death/apoptosis
    cell organization/biogenesis
    cell migration & motility
    PHYSIOLOGICAL PROCESS coagulation/hemostasis , development , immunity/defense , inflammation
    text
  • angiogenesis
  • central nervous system neuron axonogenesis
  • endothelial cell migration
  • microtubule cytoskeleton organization and biogenesis
  • neuron migration
  • PATHWAY
    metabolism
    signaling signal transduction
    a component
  • PTK2/ELK1 complex is found, mainly, in the cytoplasm, near the nuclear membrane periphery, raising the possibility that ELK1 may have alternative extranuclear function
  • PTK2-CD4 complex represents an alternative route for eliciting T-cell-specific signals and it links gp120 engagement to distinctive T-cell signalling during HIV infection
  • part of PTK2-RASA1-GRLF1 complex that regulates polarity in migrating cells
  • within FAC (focal adhesion complex), the focal adhesion kinase (PTK2) and PTK2B are believed to act as important scaffolding proteins
  • ABCB1 and an integrated component of the occludin/zonula occludens 1 (TJP1) adhesion complex at the BTB, structurally interacted with PTK2, creating the OCLN/TJP1/PTK2/ABCB1 regulatory complex
  • INTERACTION
    DNA
    RNA
    small molecule nucleotide,
  • ATP
  • protein
  • growth factor receptor-bound protein 2, GBR2
  • Crk-associated tyrosine kinase substrate p130Cas
  • talin 1, TLN1
  • Rho GTPase activating protein 26, ARHGAP26
  • neural precursor cell expressed, developmentally down-regulated 9, NEDD9
  • Syk protein-tyrosine kinase, Syk
  • protein tyrosine kinase 2 beta, PTK2B
  • transforming growth factor beta 1 induced transcript 1, TGFB1I1
  • c-Cbl-associated protein, CAP
  • Janus kinase 2, JAK2
  • insulin receptor substrate 1, IRS1
  • embryonal Fyn-associated substrate, Efs
  • growth factor receptor-bound protein 7, GBR7
  • phosphatase and tensin homolog, PTEN
  • PDGF- and EGF-receptor (PDGFR and EGFR) signalling complexes
  • EPH receptor A2, EPHA2
  • polycystic kidney disease 1, PKD1
  • transforming growth factor beta 1 induced transcript 1, TGFB1I1
  • interaction between the PH domain of Etk and the FERM domain of FAK
  • Ezrin, EZR
  • ArfGAP with SH3 domain, ankyrin repeat and PH domain 1, ASAP1
  • c-Jun N-terminal kinase (JNK)/stress activated protein kinase-associated protein 1, JSAP1
  • NCK adaptor protein 2, NCK2
  • activates Src family kinases via c-Src SH2/SH3 interactions
  • triple functional domain (PTPRF interacting), TRIO
  • protein inhibitor of activated STAT 1, PIAS1
  • calcium- and integrin-binding protein, CIB
  • potassium large conductance calcium-activated channel subfamily M alpha member 1, KCNMA1
  • death domain kinase receptor-interacting protein, RIP
  • netrin 1, NTN1
  • SAP90/PSD-95-Associated Protein-3, SAPAP3
  • N-terminal transactivation domain of p53
  • dynamin
  • tuberous sclerosis complex 2, TSC2
  • EPH receptor B2, EPHB2
  • vascular endothelial growth factor receptor-3, VEGFR3
  • CAS family members and with GIT1, SORBS1 and BCAR3
  • MAPK7
  • IGF1R (role in phosphorylation, signaling and stability of the IGF1R)
  • binding-protein partner for ELK1, a finding that significantly broadens the potential functioning of PTK2 and ELK1
  • with ARHGEF11 and ROCK2, cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts
  • DLGAP3 and ASAP1
  • IGF1R and plays an important role in cancer cell survival
  • epithelial membrane protein 2, EMP2
  • interactio with CADM1 (PTK2 is its binding partner and effector in shaping growth cones)
  • GNB1-mediated FYN activation integrates PTK2 with adherens junctions, preventing persistent endothelial barrier leakiness
  • interacting with XIAP (XIAP modulates PTK2 activity through the control of PTK2 phosphorylation)
  • scaffold and tyrosine kinase protein that binds to itself and cellular partners through its four-point-one, ezrin, radixin, moesin (FERM) domain
  • suppression of vimentin intermediate filaments by PTK2 facilitates the assembly of podosome rosettes
  • DLC1 binds to the FAT domain of PTK2 through at least some of the FAT sequences that bind paxillin, although it remains possible that other regions of PTK2 may also interact with DLC1
  • PTK2 is a novel regulator of SNAIL1-dependent epithelial-mesenchymal transition in embryonic cells
  • ABCB1 is involved in regulating BTB dynamics, likely via its interaction with PTK2, which modulates the phosphorylation status of the OCLN/TJP1 protein complex
  • cell & other
    REGULATION
    activated by tyrosine-phosphorylation in response to either integrin clustering or via G-protein coupled receptor (GPCR) occupancy by ligands such as bombesin or lysophosphatidic acid, or via LDL receptor occupancy
    integrin LFA-1
    Other acetylation
    phosphorylated via integrins or growth factor receptors
    phosphorylated by tyrosine aminotransferase, Tat
    phosphorylated bythrombin
    phosphorylated by EMP2 overexpression
    phosphorylated by ret proto-oncogene
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in hepatocellular carcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerdigestivepancreas
    targeting interaction PTK2/IGF1R with small molecules is a novel strategy for treatment of pancreatic cancer or other cancers
    ANIMAL & CELL MODELS
  • FAK-deficient mice display a general defect of mesoderm development, and cells from these embryos have reduced mobility in vitro
  • Null mutation of FAK results in embryonic lethality, and FAK-/- fibroblasts exhibit cell migration defects in culture
  • keratinocyte cell death was observed after fak deletion in vitro and in vivo in mice
  • mice in which FAK is selectively inactivated in cardiomyocytes develop eccentric cardiac hypertrophy ncreased heart/body weight ratios, elevated markers of cardiac hypertrophy, multifocal interstitial fibrosis, and increased collagen I and VI expression
  • focal adhesion kinase (FAK) conditional knockout mice display Cardiac developmental defects and eccentric right ventricular hypertrophy